Colorado-Based Biotech Co. Grabs $150M In Series E
Inscripta Inc., a Colorado-based gene editing technology company, secured $150 million in a financing round led by Fidelity Management & Research Company LLC with advice from T. Rowe Price Associates Inc....To view the full article, register now.
Already a subscriber? Click here to view full article